PubMed Central, : RMMJ Rambam Maimonides Medical Journal Rambam Health Care Campus 2023 October; 14(4): e0021. ISSN: 2076-9172Published online 2023 August 30. doi: 10.5041/RMMJ.10506

Table 3.

Results Associated with Variation in Mediator Levels in Different Skeletal Maturation Stages.

Mediator Criteria Results
Insulin-like growth factor-1 (IGF-1) Upregulation/downregulation
  • Level in pubertal stage (CS3, CS4) greater than in pre-pubertal (CS1, CS2)/pubertal (CS5, CS6) stages2022,37,43,46,48,53,56,62
  • Levels in high velocity stages (SMI 6–8) greater than in accelerating stage (SMI 4–5)/pre-pubertal (SMI 1–3)/decelerating velocity (SMI 9–10)/post-pubertal stages (SMI 11)38,61
  • Salivary IGF-1 at QCVM II (high velocity) greater than in QCVM I (accelerating velocity)/QCVM III (decelerating)/QCVM IV (completed)52
Peak levels
Sex predilection
  • Peak IGF-1 levels in F at CVMI 3;2022,44,46,49,55 CVMI 448
  • Peak IGF-1 levels in M at CVMI 420,22,49,53,56
  • Peak IGF-1 levels in M and F at CVMI 456
  • Peak levels in F greater than in M,49 and in M greater than in F23,37,38
Significant correlations
  • Positive correlation btw BALP and IGF-1 across various skeletal stages20
  • Positive correlation btw OC and IGF-1 in CVMI 1–6 (M) and CVMI 3–6,4–6 (F)22
  • Positive correlation btw IGF-1 and IGFBP-3 across CVMI 1–337,38,46
  • Positive correlation of IGF-1 levels in serum and urine across CVMI 1–448
  • Positive correlation of IGF-1 with age till CS3 and negative correlation until CS4, CS553
  • Negative correlation of IGF-1 with time of pubertal onset and age62
  • IGF-1 peak levels at CS3 in correlation with peak IGF-1 levels at MP3G stage45
Craniofacial parameters
  • Negative correlation of annual change in IGF-1% with mandibular length20
  • Positive correlation of IGF-1 increase with increasing mandibular length50
  • Positive correlation of AFH and mandibular plane change with % change in IGF-1 levels50
  • Moderate to high correlation of ascending IGF-1 levels (> 250 μg/L) to greater mandibular growth (5.6 mm)57
Growth predictive model
  • Regression model with IGF-1, ALP, and chronological age provided the best skeletal growth prediction (P<0.001)40
Bone-specific alkaline phosphatase (BALP) Upregulation/downregulation
  • BALP levels peak at CVMI 3 in both sexes20,21
  • Negative correlation of annual % change in BALP with mandibular length20
  • Salivary BALP levels in pre-pubertal stage greater in the pubertal stage greater than in post-pubertal stage21
Association with other parameters
  • BALP levels peak at CVMI 3 earlier than IGF-120,21
  • BALP more accurate than IGF-1 for skeletal maturation20
Osteocalcin (OC) Upregulation/downregulation
  • Mean serum OC levels reach peak at CVMI 5 in M, and from CVMI 322 OC levels in M greater than in F22
Correlations
  • Significant correlation btw IGF-1 and OC in CVMI 1–6 (M) (P<0.05), and CVMI 3–6, 4–6 (F) (P<0.05)22
Vitamin D binding protein (DBP) and serotransferrin (TF) Upregulation/downregulation
  • DBP and TF % in GCF in pubertal greater than in pubertal/post-pubertal stage24,45
  • In post-pubertal stage, mandibular TF greater than maxillary TF24
  • In pre-pubertal and post-pubertal stages, maxillary DBP greater than mandibular DBP24
  • No difference in TF and DBP levels in malocclusion class or sex24
Pubertal predictive model
  • Maxillary TF levels and age important variables, maxillary TF more accurate btw pubertal and non-pubertal stages, with 100% specificity and 68.2% sensitivity24
Dehydroepiandrosterone sulfate (DHEAS) Upregulation/downregulation
  • Levels of DHEAS in pubertal greater than in pre-pubertal39,44
  • Mean DHEAS levels steady increase from pre-pubertal to post-pubertal stage39,47,58
Sex predilection
  • Peak in M at CS4, and in F at CS344
  • Levels in M greater than in F at all stages except CS2, 344
Alkaline phosphatase (ALP) Upregulation/downregulation
  • Peak in early pubertal stage27
  • ALP protein concentration peaked at CVM stage 3 (1.44 [0.65] mg/mL) and CVM stage 5 (1.50 [0.46] mg/mL)27
  • GCF ALP levels in pubertal greater than in pre-pubertal/post-pubertal stage25,60
  • Total GCF ALP activity in pubertal greater than in non-pubertal stages60
Correlations
  • Significant positive correlation btw salivary ALP and age27
  • Negative correlation of GCF ALP levels with pre-pubertal/post-pubertal phase25,60
Pubertal predictive model
  • ALP and age combined proved better predictive accuracy for pubertal peak than ALP alone27
Sex predilection
  • Levels in M greater than in F27
Parathormone-related protein (PTHrP) Upregulation/downregulation
  • Serum PTHrP increase across CS1–5 with a correlation coefficient of 10.68 (P<0.001)54
  • Peak levels seen at CS5, then decline at CS6 (coefficient 0.676)54

AFH, anterior facial height; ALP, alkaline phosphatase; BALP, bone alkaline phosphatase; btw, between; CS, cervical stage; CVMI, cervical vertebral maturation index; DBP, vitamin D binding protein; F, female(s); GCF, gingival crevicular fluid; IGF-1, insulin-like growth factor; IGFBP-3, insulin-like growth factor binding protein-3; M, male(s); MP3G, middle phalanx of third finger (G stage); OC, osteocalcin; PTHrP, parathormone-related protein; QCVM, quantitative cervical vertebral maturation; SMI, skeletal maturity indicators; TF, serotransferrin.

RMMJ Rambam Maimonides Medical Journal Rambam Health Care Campus 2023 October; 14(4): e0021. ISSN: 2076-9172
Published online 2023 August 30. doi: 10.5041/RMMJ.10506